272 related articles for article (PubMed ID: 30075260)
1. Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base.
Sekar A; Rudrappa S; Gopal S; Ghosal N; Gupta V; Ts L
World Neurosurg; 2018 Nov; 119():97-102. PubMed ID: 30075260
[TBL] [Abstract][Full Text] [Related]
2. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
Inoue A; Ohnishi T; Kohno S; Nishikawa M; Nishida N; Ohue S
World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403
[TBL] [Abstract][Full Text] [Related]
3. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
Goto Y; Furuno Y; Kawabe T; Ohwada K; Tatsuzawa K; Sasajima H; Hashimoto N
J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
[TBL] [Abstract][Full Text] [Related]
4. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
[TBL] [Abstract][Full Text] [Related]
5. Unresectable Clival Giant Cell Tumor, Tumor Control With Denosumab After Relapse: A Case Report and Systematic Review of the Literature.
Pionelli MG; Asaftei SD; Tirtei E; Campello A; Di Rosa G; Fagioli F
J Pediatr Hematol Oncol; 2022 Jul; 44(5):201-209. PubMed ID: 35537059
[TBL] [Abstract][Full Text] [Related]
6. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
Yonezawa N; Murakami H; Kato S; Takeuchi A; Tsuchiya H
Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
[TBL] [Abstract][Full Text] [Related]
7. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration.
Freeman JL; Oushy S; Schowinsky J; Sillau S; Youssef AS
World Neurosurg; 2016 Dec; 96():47-57. PubMed ID: 27269210
[TBL] [Abstract][Full Text] [Related]
8. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
10. Surgical Management of Giant Cell Tumors in Temporomandibular Joint Region Involving Lateral Skull Base: A Multidisciplinary Approach.
Shen Y; Ma C; Wang L; Li J; Wu Y; Sun J
J Oral Maxillofac Surg; 2016 Nov; 74(11):2295-2311. PubMed ID: 27186869
[TBL] [Abstract][Full Text] [Related]
11. A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab.
Mak IW; Evaniew N; Popovic S; Tozer R; Ghert M
J Bone Joint Surg Am; 2014 Aug; 96(15):e127. PubMed ID: 25100780
[TBL] [Abstract][Full Text] [Related]
12. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
Bardakhchyan S; Kager L; Danielyan S; Avagyan A; Karamyan N; Vardevanyan H; Mkhitaryan S; Papyan R; Zohrabyan D; Safaryan L; Sargsyan L; Harutyunyan L; Hakobyan L; Iskanyan S; Tamamyan G
Ital J Pediatr; 2017 Mar; 43(1):32. PubMed ID: 28356124
[TBL] [Abstract][Full Text] [Related]
13. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
Dubory A; Missenard G; Domont J; Court C
Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
15. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
Tsukamoto S; Tanaka Y; Mavrogenis AF; Kido A; Kawaguchi M; Errani C
Clin Orthop Relat Res; 2020 May; 478(5):1076-1085. PubMed ID: 31794487
[TBL] [Abstract][Full Text] [Related]
16. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
[TBL] [Abstract][Full Text] [Related]
17. Current management of giant-cell tumor of bone in the denosumab era.
Nagano A; Urakawa H; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2022 May; 52(5):411-416. PubMed ID: 35199172
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
19. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
Kinoshita H; Orita S; Yonemoto T; Ishii T; Iwata S; Kamoda H; Tsukanishi T; Inage K; Abe K; Inoue M; Norimoto M; Umimura T; Fujimoto K; Shiga Y; Kanamoto H; Furuya T; Takahashi K; Ohtori S
J Med Case Rep; 2019 Apr; 13(1):116. PubMed ID: 31023361
[TBL] [Abstract][Full Text] [Related]
20. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
Sørensen AL; Hansen RL; Jørgensen PH
Ugeskr Laeger; 2016 Sep; 178(36):. PubMed ID: 27593237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
